Seroatlas · Human Serome Atlas

ATP5F1B

ATP synthase F(1) complex subunit beta, mitochondrial

Also known as: ATP5B, ATPB_HUMAN, ATPSB

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P06576
Gene
ATP5F1B
Ensembl
ENSG00000110955
Chromosome
12
Canonical length
529 aa
Protein class
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
Subcellular location
Mitochondria
Quaternary structure
Homooctamer

OverviewNCBI Gene

This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the beta subunit of the catalytic core. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

529 residues, UniProt reviewed canonical sequence.

>P06576|ATP5F1B
     1  MLGFVGRVAA APASGALRRL TPSASLPPAQ LLLRAAPTAV HPVRDYAAQT SPSPKAGAAT
    61  GRIVAVIGAV VDVQFDEGLP PILNALEVQG RETRLVLEVA QHLGESTVRT IAMDGTEGLV
   121  RGQKVLDSGA PIKIPVGPET LGRIMNVIGE PIDERGPIKT KQFAPIHAEA PEFMEMSVEQ
   181  EILVTGIKVV DLLAPYAKGG KIGLFGGAGV GKTVLIMELI NNVAKAHGGY SVFAGVGERT
   241  REGNDLYHEM IESGVINLKD ATSKVALVYG QMNEPPGARA RVALTGLTVA EYFRDQEGQD
   301  VLLFIDNIFR FTQAGSEVSA LLGRIPSAVG YQPTLATDMG TMQERITTTK KGSITSVQAI
   361  YVPADDLTDP APATTFAHLD ATTVLSRAIA ELGIYPAVDP LDSTSRIMDP NIVGSEHYDV
   421  ARGVQKILQD YKSLQDIIAI LGMDELSEED KLTVSRARKI QRFLSQPFQV AEVFTGHMGK
   481  LVPLKETIKG FQQILAGEYD HLPEQAFYMV GPIEEAVAKA DKLAEEHSS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ATP5F1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
2,993 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 2,993 nTPM
  • skeletal muscle: 2,427 nTPM
  • heart muscle: 2,013 nTPM
  • parathyroid gland: 1,231 nTPM
  • choroid plexus: 893 nTPM
  • kidney: 883 nTPM

Single-cell type

  • syncytiotrophoblasts: 1,351 nCPM
  • parietal cells: 1,278 nCPM
  • esophageal basal cells: 1,128 nCPM
  • esophageal suprabasal cells: 1,098 nCPM
  • cytotrophoblasts: 975 nCPM
  • enteric transient amplifying cells: 955 nCPM

Immune cell

  • total PBMC: 1,076 nTPM
  • non-classical monocyte: 754 nTPM
  • myeloid DC: 714 nTPM
  • intermediate monocyte: 644 nTPM
  • classical monocyte: 550 nTPM
  • basophil: 404 nTPM

Brain region

  • choroid plexus: 765 nTPM
  • hypothalamus: 472 nTPM
  • cerebral cortex: 452 nTPM
  • cerebellum: 417 nTPM
  • pons: 412 nTPM
  • thalamus: 406 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ATP5F1B.

Disease | AllUniProt

Conditions ATP5F1B is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 61 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on ATP5F1B was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.31
gnomAD pLI
0.98
DepMap mean gene effect
-0.93
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ATP5F1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ATP5F1B as an antibody target. Whether an autoantibody or antibody against ATP5F1B could matter depends on whether native ATP5F1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ATP5F1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ATP5F1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ATP5F1B. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...